Search results
Results from the WOW.Com Content Network
Ginkgo Bioworks Holdings, Inc. (DNA) closed the most recent trading day at $2.84, moving -0.35% from the previous trading session.
Ginkgo Bioworks is an American biotech company founded in 2008 by five scientists from MIT, [3] headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology.
Get breaking Business News and the latest corporate happenings from AOL. From analysts' forecasts to crude oil updates to everything impacting the stock market, it can all be found here.
For premium support please call: 800-290-4726 more ways to reach us
[2] [3] In October 2023 it announced a 1 for 15 reverse stock split so it could regain the stock exchange's required US$1 per share stock price. [4] Danny Yeung is CEO of Prenetics. [5] Prenetics has become the first Hong Kong–based unicorn to list on Nasdaq following a merger with a Special-purpose acquisition company Artisan Acquisition ...
In May 2021, Inovio announced the results of preclinical studies on a "pan-SARS-CoV-2" DNA vaccine (INO-4802) and plans to initiate phase I/II studies. The vaccine incorporates common overlapping mutations from several SARS-COV-2 variants of concern isolated from several different countries including Brazil and India.
Based on AMD's trailing 12-month non-GAAP earnings per share (EPS) of $3, its stock currently trades at a price-to-earnings (P/E) ratio of 39.1. That's a 17% discount to Nvidia's P/E ratio of 47.1 ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!